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ealth communicationThe recent ﬂurry of publications from the WHO  SAGE Working
roup on the growing challenge of vaccine hesitancy provides some
mportant insights into this often misunderstood phenomenon [1].
n important caveat is that vaccine hesitancy is not a growing
enace, it has been a constant and steady threat to immuniza-
ion programs since Jenner ﬁrst started inoculating people from
owpox blisters. At present, immunization rates of children in
ost countries are stable or even increasing [2], but clustering
f under-vaccinated individuals may  increase the risk of disease
utbreaks.
The ﬁrst insight is that the problem lies mainly with the hes-
tancy of people to vaccinate, and not with vaccine refusers who
epresent a very small, albeit often outspoken, minority [3]. Sec-
ndly, vaccine hesitancy is a complex and ﬂuid challenge with
yriad possible demographic or socio-psychological root causes,
hich change with context and over time [4,5]. There is no quick
nd easy ﬁx. Thirdly, educating people alone has little or no impact
n vaccine hesitancy [6–8]. Thus, research and development, of
quivalent rigor to that done to develop vaccines and vaccination
rograms, is needed to develop the tools to monitor vaccine hesi-
ancy, to understand the root causes of hesitancy in each context,
o tailor solutions accordingly, and to measure impact of interven-
ions [4,9]. Finally, consistent with a large body of research, the
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264-410X/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article unWHO  conﬁrms the important position of healthcare professionals
(HCPs) as the cornerstone of public acceptance of vaccination.
To these WHO  recommendations we  add two  fundamental con-
siderations that have emerged from our research. First, hesitancy
must be viewed in context. Even where vaccination refusal is sus-
pected, hesitancy is often not the primary cause of incomplete
immunization [10,11]. The root causes of suboptimal vaccination
coverage may  be due to challenges to Access, Affordability, Aware-
ness, Acceptance (hesitancy) or Activation (5As taxonomy) [12,13].
Second, the foundation of vaccination acceptance is public trust;
trust in vaccines and vaccine producers, in the healthcare profes-
sion and the government [14].
The evidence base on effective interventions is still incomplete
and further rigorous research and development is needed to ﬁll the
gaps [9]. However, there is a need to act now. Here, we draw upon
the existing evidence to propose some practical recommendations
for HCPs (Table 1) and Public Health professionals to effectively
address vaccine hesitancy, with the caveat that all of these recom-
mendations should be further tested for efﬁcacy upon vaccination
attitudes, intentions and behaviors.
1. What can immunization partners do here and now?Accountability should be taken by governments for the immu-
nization rates in every program, but then all partners (national
immunization programs, public health departments, academia,
HCPs, manufacturers, Civil Society Organizations, global agencies,
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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evelopment partners, private sector) should mobilize and collab-
rate to ensure the sustained success of immunization programs
15]. Partners can start with three shared objectives: (i) communi-
ate proactively on immunization, (ii) prepare for issues that may
rise, and (iii) understand the challenge better through existing and
uture research.
.1. Remind the public why we vaccinate
Emphasize the positive; how vaccination protects people and
eeps them healthy. Reinforce the social norm of vaccination, as
eople will do what they think everyone else is doing [16]. But do
ot try to scare people, as fear can backﬁre [17]. Acknowledge that
accines may  commonly have mild side effects and very rarely may
ause serious adverse reactions; this may  actually lower perceived
isk [18]. Rigorous monitoring of vaccine safety is often poorly com-
unicated to the public. Whilst it should be reassuring, it is often
isinterpreted when correlation is confused with causation. Have
rustworthy alternative voices join the conversation as well: HCPs,
arents, Civil Society Organizations, and community leaders.
.2. Proactively engage with the news media
Take the story to the press. Give them the information, stories,
nd answers they need to write about vaccines or possible emerg-
ng issues. Provide them with independent science commentary
19]. Vaccination-related issues have been fueled by media sensa-
ionalism and by poor journalism that gives ‘false balance’ in which,
or example, anecdotal stories are presented as the counterbalance
or strong scientiﬁc evidence [20]. Help journalists understand the
isks of this approach for public health where the scientiﬁc evi-
ence is overwhelmingly in favor of vaccination (or other public
ealth measures).
.3. Proactively engage in social media
Effective engagement in social media requires content and
each. Every country should have a trusted hub of resonant,
rustworthy information, answers, stories, and videos that is the
eference for the public when they have questions about vacci-
ation. The European website Vaccines Today is a good model
or such an online reference [21]. Reach comes through effective
ocial media strategies that share content in multiple channels and
evelop and connect positive voices online.
.4. Monitor the vaccination conversation and acceptance
The ongoing public conversation on vaccination in mainstream
nd social media can be monitored with tools such as the open-
ccess Vaccine Sentimeter [22]. Routine monitoring of the current
opics, sentiment, questions and issues could help immunization
rograms to: (i) better understand and address public concerns, (ii)
apidly identify, analyze and respond to emerging controversies,
nd (iii) measure impact of vaccination campaigns.
.5. Be prepared for vaccine-related issues
Plan to be able to listen to and understand an emerging pub-
ic concern, know who will respond and where they will engage
ith the media and the public, prepare for an ongoing conver-
ation not just distribution of short statements and fact sheets.
overnments make risk communication plans for other threats,
hey should do likewise for vaccination programs [23]. Trust is the
edrock of vaccination acceptance; be transparent and honest, and
ave the trusted alternative voices ready to speak as well. Belgium
anaged the H1N1 pandemic by following key risk managemente 34 (2016) 1989–1992
principles including ongoing regular engagement with the media,
plain language, empathy and listening to the public [24].
1.6. Invest in research, capacity building, monitoring and
evaluation of immunization programs
Research agencies and governments should begin to fund rigor-
ous research into understanding and addressing vaccine hesitancy,
and support the development of effective monitoring and evalua-
tion approaches [9]. Regional and national immunization advisory
groups should add vaccine hesitancy to their remit [4].
1.7. Empower, equip and galvanize HCPs
HCPs are the cornerstone of public acceptance of vaccination.
They need to know this, to be valued for this, and to be equipped
to help people make healthy decisions like vaccinating.
2. What can a healthcare provider do here and now?
2.1. Understand the importance of your recommendation and
example
People trust HCPs more than any other voice on vaccination. A
recommendation from a HCP is consistently cited a primary reason
for vaccination [5,25]. Establish rapport (look at the person, not the
computer) and positive common ground (It’s great to see Jo in good
form).
2.2. Present vaccination as the default
Take a ﬁrm presumptive approach, but avoid being paternalistic
or dismissive [26]. Start with a statement that assumes vaccination
will occur (Today we are going to give Jo her shots to keep her ﬁt and
healthy), not a question (Do you have any questions about today’s vac-
cines?). If no concerns arise, vaccinate and congratulate (Well done,
together we’ve helped protect Jo against some pretty nasty diseases).
This reinforces the norm of vaccination, and leaves the person with
a positive ﬁnal recollection. Set an appointment for the next shots
right away, and send a reminder close to the date [27].
2.3. Alert the patient to possible local reactions
Science clearly distinguishes between local reactions and very
rare serious adverse events following immunization (AEFI), but
people often do not see the difference. Prepare the person to iden-
tify, manage, and appreciate local reactions or mild fever (It shows
the vaccine is working), so there are no surprises or unnecessary
anxiety. If a parent reports that their child has already experienced
an AEFI, they may  be more concerned about safety [28].
2.4. Address one concern
If a concern is raised, listen to it. Let the person ﬁnish; physi-
cians interrupted within 23 s on average in one study [29]. You
do not have to acknowledge the validity of the actual concern,
but you should acknowledge the person’s right to have a question.
Say something positive about the person. Afﬁrmation increases the
chance someone will accept correct information (I can see you are
a caring parent who wants to do everything keep Jo healthy and safe.)
[30]. Respond with a simple, resonant and, if possible, tested answer
(There is more formaldehyde in a pear than in all the vaccines a child
receives).
 Vaccine 34 (2016) 1989–1992 1991
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Table 1
Talking vaccination: some rules of thumb.
Remember importance of your recommendation and example
Present vaccination as the default
Alert to local reactions
Address one concern
But
Listen ﬁrst
Beware of debunking myths
Use facts sparingly
Be careful with fear
Maintain your authority
Have your own vaccination story
If multiple concerns, elicit underlying beliefs
Minimize pain of vaccine
reﬁned by further rigorous research on understanding and sustain-
ing public trust in vaccination programs (Table 1).A. Thomson, M. Watson /
.5. Beware of debunking myths
Just repeating a myth, even to refute it, can lead people to recall
t as being true [31]. If you repeat “Vaccines don’t cause autism”,
eople may  subsequently simply associate Vaccines and autism.
tating ﬁrmly that there is “no risk” will actually increase percep-
ion of vaccination risk [18]. Acknowledge the presence of a risk
ith vaccination (just as there is a risk taking a bath, driving a car,
n everything we do in life), and describe brieﬂy the known risks of
accination; distinguish clearly between local reactions and severe
nd very rare events.
.6. Use facts sparingly
Information and education alone do not change beliefs or behav-
or. Facts can polarize people, solidify their beliefs, and may  actually
ackﬁre [32,33]. We  all have a strong cognitive bias that leads us
o favor information that conﬁrms our beliefs and reject facts that
ontradict them (conﬁrmation bias) [34]. It is easier to rationalize
han to be rational. As Socrates said, logos (logic, facts) is necessary,
ut to convince people it must be delivered with pathos and ethos
credibility, authority).
.7. Wield the double-edged sword of fear with care
Fear appeals may  work [35] or they may  backﬁre [17], but fear
s certainly not sustainable. It is an unpleasant emotional state
hat evokes physiological arousal directed at reducing or displac-
ng the fear. To have a positive effect, both the perceived threat and
erceived self-efﬁcacy must be high [36], and this is hard to achieve.
ield fear with great care. Or better still, focus on vulnerability and
ikelihood of infection [37].
.8. Maintain your authority
State that through your research and clinical experience you are
ertain that vaccination is the right thing for the person. Remind
he person that they trust you on all other matters regarding their
hild’s health. They should also trust you on this, because you are
n expert and someone who wants the best for their child.
.9. Have your own vaccination story
We  understand our world through metaphors and narrative.
ave your personal story. Something from your experience which
llustrates why you vaccinate and why you recommend vaccina-
ion, that people can relate to. It might just be “I am a parent as well,
nd my  kids and I are fully vaccinated”, or “As a young man I had two
ropical infections and was very sick for a long time. Now I do whatever
 can to protect myself and my  kids from becoming that sick.”
Eula Biss understands the power of metaphor when she notes
hat vaccines produce natural immunity because they “invite the
mmune system to produce its own protection.” The antibodies that
rotect us are “manufactured in the human body, not in factories.”
38]. Try to then mix  a bit of scientiﬁc data and your personal
xperience into “storytelling with science” [39].
.10. If multiple concerns emerge, seek the underlying fears or
eliefs
If a number of concerns are raised they may  reﬂect a deeper
ssue. Stop and try to understand the underlying beliefs or fears.
ry to understand why these issues got traction. Can you nest vac-
ination within their beliefs [40]? Can you frame the consequences
f not vaccinating within their projected future, and make those
onsequences tangible, relevant, unsettling (Jo may  avoid infectionRemain presumptive to the end
now, because everyone around her is vaccinated, but what if she were
to catch measles or rubella as a young woman working in an NGO in
Africa?)?
Parents may  be seeking an explanation for an idiopathic
condition. Most diseases wrongly associated with vaccination
(autism, multiple sclerosis, encephalopathies) are: idiopathic, hard
to explain, have dreaded outcomes, are apparently increasing in
incidence, and manifest contemporaneously with vaccination [41].
Acknowledge the difﬁculty of coping with a child with such a con-
dition.
Trust is the bedrock of vaccination acceptance [14]. Crises of
public conﬁdence in vaccination often arise after other health
crises that were mishandled by authorities (e.g., bovine spongiform
encephalopathy in the UK) [41]. Remember that they probably still
trust you, build on that [14].
Concerns around ingredients in vaccines may  be rooted in a ‘nat-
ural’ worldview wherein ‘toxins’ everywhere threaten our health
[38]. They may  also be masking omission bias (fear of causing harm
by acting is greater than that by not acting).  Remind people that there
is a real risk to doing nothing, especially if others in the community
are also not vaccinating.
Someone who  believes a conspiracy theory is probably using it
to reduce the complexity of reality and contain uncertainty, and is
more likely to believe additional conspiracy narratives [42]. Their
belief may  be underpinned by feelings of powerlessness, disillu-
sionment and mistrust in authorities [43]. Concentrate on securing
their trust, which may  take more than one consultation.
2.11. It can’t hurt to minimize pain
You may  be overestimating parental concerns related to multi-
ple injections and pain in infants [44], but you can still do things to
keep it to a minimum [45].
2.12. Remain presumptive to the end
A mind is a hard thing to change. Stay the course, continue to
recommend at end of this discussion regardless of the outcome.
Treat this encounter as part of an ongoing conversation with the
person.
This practical guide is just a ﬁrst version, to be developed andConﬂict of interest statement
AT and MW are employed by Sanoﬁ Pasteur.
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